Cusack Archives | EMBL
Paving the way for new flu drugs
Snapshots of the flu virus replication machine in action
Flu’s response to new drug explored
EMBL scientists investigate how influenza virus responds to new drug treatment
Futures: Unravelling influenza
ERC grantee Stephen Cusack shares his vision for the next ten years
How flu steals your RNA
Understanding how the flu virus steals host RNA offers hope of new drugs
New Crystallography platform inaugurated
A new crystallography platform in Grenoble opens the door to new technological developments
New drug candidate unleashed for TB
EMBL researchers help to design a lead compound active against four different pathogens
Opinion: 2006, a year of champagne
Stephen Cusack looks back on the early days of his collaboration with Anacor developing anti-infectives
Opinion: A journey from bench to clinical trials
Andrés Palencia on the design of compounds that may help fight drug-resistant TB and more
Found in translation
Studying at EMBL in Grenoble helps Japanese postdoc see her native country through different eyes
Molecular momentum
Andrew Miller, first head of EMBL Grenoble, reflects on four decades at the Outstation.
